Ivan Titov

A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)

Ivan Titov, Richard G. Wunderink, Antoine Roquilly et al. · Clinical Infectious Diseases · 2020 · 213 citations · Full text

Ceftobiprole for Treatment of Complicated <i>Staphylococcus aureus</i> Bacteremia

Thomas L Holland, Sara E. Cosgrove, Sarah B. Doernberg et al. · New England Journal of Medicine · 2023 · 87 citations

Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial

Yehuda Carmeli, José Miguel Cisneros, Mical Paul et al. · The Lancet Infectious Diseases · 2024 · 75 citations

Aztreonam–avibactam Versus Meropenem, Antimicrobial Susceptibility, Antibiotics +13

2893 A. Efficacy and Safety of Aztreonam-Avibactam for the Treatment of Serious Infections Due to Gram-Negative Bacteria, Including Metallo-β-Lactamase-Producing Pathogens: Phase 3 REVISIT Study

Yehuda Carmeli, Jose-Miguel Cisneros, Mical Paul et al. · Open Forum Infectious Diseases · 2023 · 25 citations · Full text

Mbl-producing Mdr Pathogens, Antimicrobial Chemotherapy, Bacterial Pathogens +24